Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Israel
  4. TEL AVIV STOCK EXCHANGE
  5. Itamar Medical Ltd.
  6. Summary
    ITMR   IL0011024580

ITAMAR MEDICAL LTD.

(ITMR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Tel Aviv Stock Exchange
07/25/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
206(c) 204.2(c) 200(c) 204(c) 210.1 Last
528 935 845 046 1 331 200 1 861 158 609 948 Volume
+0.29% -0.87% -2.06% +2.00% +2.99% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 52,6 M - -
Net income 2021 -15,9 M - -
Net Debt 2021 - - -
P/E ratio 2021 -15,6x
Yield 2021 -
Sales 2022 69,2 M - -
Net income 2022 -6,65 M - -
Net Debt 2022 - - -
P/E ratio 2022 -42,1x
Yield 2022 -
Capitalization 309 M 309 M -
Capi. / Sales 2021 5,87x
Capi. / Sales 2022 4,46x
Nbr of Employees 257
Free-Float 81,7%
More Financials
Company
Itamar Medical is a medical device company based in Israel. The Company develops and markets innovative diagnostic and therapy solutions for sleep breathing disorders and cardiovascular conditions. The Company's flagship product WatchPAT is used for diagnosing sleep apnea in the home environment. WatchPAT is an easy-to-use patient-led alternative with abilities to interpret test results automatically, as well as... 
More about the company
Ratings of Itamar Medical Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ITAMAR MEDICAL LTD.
07/28ITAMAR MEDICAL : to Report Second Quarter Financial Results and Host Conference ..
PU
07/28Itamar Medical to Report Second Quarter Financial Results and Host Conference..
GL
06/30Itamar Medical to Present at the Ladenburg Thalmann Annual Healthcare Confere..
GL
06/07Itamar Medical Ltd. Launches Enhancements to WatchPATÖ Product Line at SLEEP ..
CI
05/19ITAMAR MEDICAL : Q1 Adjusted Loss Widens, Revenue Rises; Reaffirms Full-Year 202..
MT
05/19ITAMAR MEDICAL : REPORTS FIRST QUARTER 2021 RESULTS (Form 6-K)
PU
05/19Itamar Medical Reports First Quarter 2021 Results
GL
05/05ITAMAR MEDICAL : to Report First Quarter Financial Results and Host Conference C..
AQ
03/08ITAMAR MEDICAL : HC Wainwright & Co. Adjusts Price Target on Itamar Medical to $..
MT
03/02ITAMAR MEDICAL : Q4 Adjusted Loss Widens, Revenue Gains; Issues Full-Year 2021 R..
MT
03/02Itamar Medical Reports Record Fourth Quarter and Full Year 2020 Revenues
GL
02/16ITAMAR MEDICAL : to Report Fourth Quarter and Full Year 2020 Financial Results a..
AQ
02/16ITAMAR MEDICAL : 89% of Survey Participants Think They Know What Sleep Apnea Is,..
AQ
02/11Itamar Medical to Participate in Upcoming Investor Conferences
GL
02/10ITAMAR MEDICAL : Announces Closing of Public Offering of American Depositary Sha..
AQ
More news
News in other languages on ITAMAR MEDICAL LTD.

- No features available -

More news
Analyst Recommendations on ITAMAR MEDICAL LTD.
More recommendations
Chart ITAMAR MEDICAL LTD.
Duration : Period :
Itamar Medical Ltd. Technical Analysis Chart | ITMR | IL0011024580 | MarketScreener
Technical analysis trends ITAMAR MEDICAL LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 3
Last Close Price 2,04 ILS
Average target price 3,02 ILS
Spread / Average Target 48,0%
EPS Revisions
Managers and Directors
Gilad Glick President, CEO & VP-Sales & Marketing
Shy Basson Chief Financial Officer
Giora Yaron Chairman
Efrat Litman Vice President-Advanced Research & Development
Jennifer Cook Global Medical Director
Sector and Competitors